BioRem Historical Balance Sheet

BRM Stock

CAD 3.00 0.02 0.67%

Trend analysis of BioRem Inc balance sheet accounts such as Short Long Term Debt Total of 2.9 M, Other Current Liabilities of 2 M or Total Current Liabilities of 7.9 M provides information on BioRem's total assets, liabilities, and equity, which is the actual value of BioRem Inc to its prevalent stockholders. By breaking down trends over time using BioRem balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining BioRem Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether BioRem Inc is a good buy for the upcoming year.

BioRem Inventory

764,800

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioRem Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About BioRem Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of BioRem Inc at a specified time, usually calculated after every quarter, six months, or one year. BioRem Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of BioRem and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which BioRem currently owns. An asset can also be divided into two categories, current and non-current.

BioRem Balance Sheet Chart

At this time, BioRem's Non Currrent Assets Other are fairly stable compared to the past year. Property Plant Equipment is likely to climb to about 1.4 M in 2024, whereas Short and Long Term Debt Total is likely to drop slightly above 2.9 M in 2024.

Total Assets Other Current Liab Total Current Liabilities Retained Earnings Net Receivables

Total Assets

Total assets refers to the total amount of BioRem assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in BioRem Inc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on BioRem balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of BioRem Inc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Retained Earnings

The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.

Most accounts from BioRem's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into BioRem Inc current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioRem Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2021	2022	2023	2024 (projected)
Short and Long Term Debt Total	5.7M	4.7M	4.2M	2.9M
Total Assets	19.2M	20.7M	24.1M	15.1M

Short Long Term Debt Total Total Assets

BioRem balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Accounts Payable	Current Deferred Revenue	Good Will	Intangible Assets	Non Currrent Assets Other
Total Assets		-0.06	0.67	0.67	0.77	0.58	-0.5	0.52	0.7	0.87	0.7	0.85	0.48	0.18	0.51	0.26	-0.49	0.61	0.99	-0.47	0.06	0.74	0.67	-0.23	-0.59	0.85
Short Long Term Debt Total	-0.06		0.26	0.55	-0.63	0.38	0.76	0.14	-0.36	0.01	-0.36	0.07	-0.42	0.81	0.04	0.28	0.25	0.7	-0.08	0.54	-0.7	0.35	0.23	-0.17	-0.02	0.05
Other Current Liab	0.67	0.26		0.56	0.33	0.52	-0.18	0.67	0.46	0.75	0.46	0.53	-0.01	0.58	0.29	-0.03	-0.41	0.64	0.61	-0.35	-0.44	0.46	0.35	-0.02	-0.04	0.67
Total Current Liabilities	0.67	0.55	0.56		0.08	0.54	0.18	0.22	0.13	0.49	0.13	0.77	0.17	0.57	0.34	0.38	-0.08	0.95	0.69	0.18	-0.25	0.91	0.67	-0.17	-0.56	0.44
Total Stockholder Equity	0.77	-0.63	0.33	0.08		0.25	-0.87	0.35	0.82	0.69	0.82	0.5	0.63	-0.39	0.37	0.06	-0.52	-0.03	0.76	-0.65	0.47	0.24	0.33	-0.13	-0.44	0.68
Property Plant And Equipment Net	0.58	0.38	0.52	0.54	0.25		0.09	0.64	0.29	0.64	0.27	0.43	-0.11	0.59	0.42	0.74	-0.17	0.6	0.51	-0.14	-0.36	0.52	0.82	-0.75	-0.25	0.72
Net Debt	-0.5	0.76	-0.18	0.18	-0.87	0.09		-0.05	-0.86	-0.45	-0.86	-0.15	-0.67	0.56	-0.37	0.27	0.39	0.3	-0.5	0.59	-0.63	0.1	0.03	-0.26	0.28	-0.35
Retained Earnings	0.52	0.14	0.67	0.22	0.35	0.64	-0.05		0.27	0.62	0.25	0.44	-0.14	0.47	0.09	0.22	-0.68	0.38	0.45	-0.57	-0.64	0.32	0.47	-0.53	0.21	0.77
Cash	0.7	-0.36	0.46	0.13	0.82	0.29	-0.86	0.27		0.69	1.0	0.26	0.66	-0.2	0.59	-0.03	-0.43	0.08	0.67	-0.47	0.38	0.13	0.26	0.04	-0.46	0.64
Non Current Assets Total	0.87	0.01	0.75	0.49	0.69	0.64	-0.45	0.62	0.69		0.69	0.58	0.25	0.34	0.55	0.22	-0.35	0.51	0.79	-0.46	-0.09	0.51	0.47	-0.2	-0.32	0.91
Cash And Short Term Investments	0.7	-0.36	0.46	0.13	0.82	0.27	-0.86	0.25	1.0	0.69		0.26	0.66	-0.21	0.58	-0.06	-0.42	0.08	0.67	-0.47	0.38	0.13	0.23	0.08	-0.46	0.62
Net Receivables	0.85	0.07	0.53	0.77	0.5	0.43	-0.15	0.44	0.26	0.58	0.26		0.34	0.23	0.18	0.24	-0.44	0.71	0.88	-0.32	-0.09	0.89	0.69	-0.24	-0.52	0.61
Common Stock Shares Outstanding	0.48	-0.42	-0.01	0.17	0.63	-0.11	-0.67	-0.14	0.66	0.25	0.66	0.34		-0.55	0.2	-0.14	-0.38	-0.02	0.53	-0.09	0.61	0.22	0.18	0.15	-0.67	0.27
Non Current Liabilities Total	0.18	0.81	0.58	0.57	-0.39	0.59	0.56	0.47	-0.2	0.34	-0.21	0.23	-0.55		0.22	0.26	0.1	0.76	0.12	0.07	-0.8	0.48	0.35	-0.24	0.2	0.3
Inventory	0.51	0.04	0.29	0.34	0.37	0.42	-0.37	0.09	0.59	0.55	0.58	0.18	0.2	0.22		0.27	-0.06	0.35	0.48	-0.27	0.17	0.38	0.41	-0.1	-0.43	0.45
Other Current Assets	0.26	0.28	-0.03	0.38	0.06	0.74	0.27	0.22	-0.03	0.22	-0.06	0.24	-0.14	0.26	0.27		0.12	0.33	0.24	0.18	-0.1	0.39	0.7	-0.81	-0.41	0.37
Other Stockholder Equity	-0.49	0.25	-0.41	-0.08	-0.52	-0.17	0.39	-0.68	-0.43	-0.35	-0.42	-0.44	-0.38	0.1	-0.06	0.12		-0.12	-0.5	0.6	0.23	-0.2	-0.34	0.21	0.02	-0.54
Total Liab	0.61	0.7	0.64	0.95	-0.03	0.6	0.3	0.38	0.08	0.51	0.08	0.71	-0.02	0.76	0.35	0.33	-0.12		0.61	0.08	-0.49	0.86	0.64	-0.2	-0.38	0.48
Total Current Assets	0.99	-0.08	0.61	0.69	0.76	0.51	-0.5	0.45	0.67	0.79	0.67	0.88	0.53	0.12	0.48	0.24	-0.5	0.61		-0.44	0.1	0.77	0.67	-0.19	-0.64	0.77
Short Term Debt	-0.47	0.54	-0.35	0.18	-0.65	-0.14	0.59	-0.57	-0.47	-0.46	-0.47	-0.32	-0.09	0.07	-0.27	0.18	0.6	0.08	-0.44		0.0	-0.09	-0.19	0.11	-0.18	-0.48
Common Stock	0.06	-0.7	-0.44	-0.25	0.47	-0.36	-0.63	-0.64	0.38	-0.09	0.38	-0.09	0.61	-0.8	0.17	-0.1	0.23	-0.49	0.1	0.0		-0.18	-0.15	0.27	-0.5	-0.19
Accounts Payable	0.74	0.35	0.46	0.91	0.24	0.52	0.1	0.32	0.13	0.51	0.13	0.89	0.22	0.48	0.38	0.39	-0.2	0.86	0.77	-0.09	-0.18		0.75	-0.31	-0.56	0.53
Current Deferred Revenue	0.67	0.23	0.35	0.67	0.33	0.82	0.03	0.47	0.26	0.47	0.23	0.69	0.18	0.35	0.41	0.7	-0.34	0.64	0.67	-0.19	-0.15	0.75		-0.73	-0.54	0.64
Good Will	-0.23	-0.17	-0.02	-0.17	-0.13	-0.75	-0.26	-0.53	0.04	-0.2	0.08	-0.24	0.15	-0.24	-0.1	-0.81	0.21	-0.2	-0.19	0.11	0.27	-0.31	-0.73		0.15	-0.49
Intangible Assets	-0.59	-0.02	-0.04	-0.56	-0.44	-0.25	0.28	0.21	-0.46	-0.32	-0.46	-0.52	-0.67	0.2	-0.43	-0.41	0.02	-0.38	-0.64	-0.18	-0.5	-0.56	-0.54	0.15		-0.37
Non Currrent Assets Other	0.85	0.05	0.67	0.44	0.68	0.72	-0.35	0.77	0.64	0.91	0.62	0.61	0.27	0.3	0.45	0.37	-0.54	0.48	0.77	-0.48	-0.19	0.53	0.64	-0.49	-0.37

Click cells to compare fundamentals

BioRem Account Relationship Matchups

BioRem balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	17.6M	22.0M	19.2M	20.7M	24.1M	15.1M
Other Current Liab	1.9M	3.3M	3.4M	4.2M	2.7M	2.0M
Total Current Liabilities	5.9M	7.8M	13.2M	12.9M	13.9M	7.9M
Total Stockholder Equity	11.7M	13.5M	2.0M	4.5M	6.7M	6.0M
Property Plant And Equipment Net	372.9K	1.4M	1.1M	1.0M	2.0M	2.1M
Net Debt	(6.4M)	(8.0M)	1.2M	971.1K	1.9M	2.0M
Retained Earnings	(9.1M)	(7.0M)	(5.7M)	(4.1M)	(1.9M)	(2.0M)
Cash	6.5M	8.9M	4.5M	3.8M	2.3M	3.1M
Non Current Assets Total	3.1M	3.7M	3.0M	3.0M	3.5M	1.9M
Cash And Short Term Investments	6.5M	8.9M	4.5M	3.8M	2.3M	2.7M
Net Receivables	5.7M	7.6M	10.1M	12.2M	15.1M	7.8M
Common Stock Shares Outstanding	38.7M	39.5M	37.4M	17.6M	17.1M	22.9M
Liabilities And Stockholders Equity	17.6M	22.0M	19.2M	20.7M	24.1M	15.1M
Inventory	1.3M	944.8K	901.7K	888.0K	901.1K	764.8K
Other Current Assets	1.0M	857.3K	658.9K	870.6K	2.3M	2.4M
Other Stockholder Equity	2.2M	2.2M	2.2M	2.3M	2.4M	2.3M
Total Liab	5.9M	8.4M	17.2M	16.2M	17.4M	9.0M
Total Current Assets	14.5M	18.3M	16.2M	17.8M	20.6M	12.4M
Accounts Payable	2.4M	1.8M	5.1M	4.7M	6.1M	3.4M
Accumulated Other Comprehensive Income	1.4M	1.1M	597.3K	1.4M	1.3M	653.8K
Current Deferred Revenue	1.6M	2.5M	3.0M	2.6M	4.3M	4.5M
Net Tangible Assets	12.9M	11.7M	13.5M	2.0M	2.3M	2.1M
Property Plant Equipment	262.5K	372.9K	1.4M	1.1M	1.3M	1.4M
Net Invested Capital	11.7M	13.5M	7.0M	8.8M	9.7M	8.1M
Net Working Capital	8.6M	10.5M	2.9M	4.9M	6.7M	5.8M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for BioRem Stock Analysis

When running BioRem's price analysis, check to measure BioRem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRem is operating at the current time. Most of BioRem's value examination focuses on studying past and present price action to predict the probability of BioRem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRem's price. Additionally, you may evaluate how the addition of BioRem to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

BioRem Historical Balance Sheet

BioRem Inventory

764,800

About BioRem Balance Sheet Analysis

BioRem Balance Sheet Chart

Total Assets

Total Current Liabilities

Retained Earnings

BioRem balance sheet Correlations

BioRem Account Relationship Matchups

High Positive Relationship

High Negative Relationship

BioRem balance sheet Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for BioRem Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 0.99	Total Assets
Total Liab	+ 0.95	Total Current Liabilities
Accounts Payable	+ 0.91	Total Current Liabilities
Non Currrent Assets Other	+ 0.91	Non Current Assets Total
Accounts Payable	+ 0.89	Net Receivables

Net Debt	- 0.87	Total Stockholder Equity
Cash And Short Term Investments	- 0.86	Net Debt
Cash	- 0.86	Net Debt
Good Will	- 0.81	Other Current Assets
Common Stock	- 0.8	Non Current Liabilities Total
Good Will	- 0.75	Property Plant And Equipment Net